Abbreviated gadoxetic acid–enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol
Registered at Clinical Research Information Service on May 22, 2022 (KCT0007417) and ClinicalTrials.gov on March 9, 2024 (NCT06312826). Participant recruitment began on August 26, 2022. Follow-up is ongoing.
Authors
- Seong Ho Park (ORCID: https://orcid.org/0000-0002-1257-8315)
- S T Kim
- Su‐Yeon Choi (ORCID: https://orcid.org/0000-0001-9977-4740)
- Han Chu Lee (ORCID: https://orcid.org/0000-0002-7631-4124)
- Dong Wook Kim (ORCID: https://orcid.org/0000-0001-7887-657X)
- Y-J Lim
- Jonggi Choi
- Hyo Jung Park
- Sung Won Chung
- Ju Hyun Shim
- Danbi Lee
- Amit G. Singal
- Won-Mook Choi
- Min-Ju Kim
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1097/hc9.0000000000000839
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00